Home › with Excess of Blasts Refractory Anemia › New York
with Excess of Blasts Refractory Anemia clinical trials in New York
3 studies for with Excess of Blasts Refractory Anemia are looking for participants at sites in New York.
Cities in New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Roswell Park Comprehensive Cancer Center, Buffalo
- New York University Langone Hospital - Long Island, Mineola
- Perlmutter Cancer Center - 34th Street, New York
- and 2 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT04256317A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
RecruitingPhase 2
Ages 18 to 66 · All sexes · Updated Mar 17, 2026 · NCT06859424Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Up to age 21 · All sexes · Updated Mar 13, 2026 · NCT04644016From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.